NasdaqGS - Delayed Quote • USD
Anavex Life Sciences Corp. (AVXL)
At close: April 25 at 4:00 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 73,380 | 1 |
| Sales | 73,380 | 1 |
| Net Shares Purchased (Sold) | 0 | 2 |
| Total Insider Shares Held | 2.58M | -- |
| % Net Shares Purchased (Sold) | 0.00% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MISSLING CHRISTOPHER U Chief Executive Officer | Sale at price 5.11 per share. | Direct | 374,972 | Mar 28, 2024 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Conversion of Exercise of derivative security at price 1.32 per share. | Direct | 96,862 | Mar 28, 2024 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Conversion of Exercise of derivative security at price 1.60 per share. | Direct | 800,000 | Jun 29, 2023 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Sale at price 7.98 per share. | Direct | 2,139,310 | Jun 28, 2023 |
| SKARPELOS ATHANASIOS Director | Sale at price 9.06 per share. | Direct | 453,000 | May 25, 2022 |
| SKARPELOS ATHANASIOS Director | Conversion of Exercise of derivative security at price 0.92 per share. | Direct | 46,000 | May 25, 2022 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Sale at price 26.00 per share. | Direct | 1,342,120 | Jun 29, 2021 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Conversion of Exercise of derivative security at price 1.32 per share. | Direct | 68,138 | Jun 29, 2021 |
| BOENISCH SANDRA Officer and Treasurer | Sale at price 26.53 per share. | Direct | 4,422,445 | Jun 29, 2021 |
| BOENISCH SANDRA Officer and Treasurer | Conversion of Exercise of derivative security at price 3.28 - 5.92 per share. | Direct | 699,163 | Jun 29, 2021 |
| FAVUS ELLIOT J. M.D. Director | Sale at price 11.70 per share. | Direct | 1,696,282 | May 21, 2021 |
| FAVUS ELLIOT J. M.D. Director | Conversion of Exercise of derivative security at price 0.92 - 6.11 per share. | Direct | 280,820 | May 21, 2021 |
| DONHAUSER PETER D.O. Director | Purchase at price 10.93 per share. | Direct | 10,930 | May 17, 2021 |
| FAVUS ELLIOT J. M.D. Director | Sale at price 12.66 per share. | Direct | 1,841,855 | Feb 24, 2021 |
| FAVUS ELLIOT J. M.D. Director | Conversion of Exercise of derivative security at price 2.58 - 3.28 per share. | Direct | 445,390 | Feb 24, 2021 |
| DONHAUSER PETER D.O. Director | Purchase at price 12.62 - 12.97 per share. | Direct | 14,760 | Feb 19, 2021 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 2.92 per share. | Direct | 3,971 | Mar 7, 2018 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 2.73 per share. | Direct | 3,958 | Mar 6, 2018 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 2.63 per share. | Direct | 3,945 | Mar 5, 2018 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 2.41 per share. | Direct | 3,976 | Mar 2, 2018 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.39 per share. | Direct | 1,646 | Oct 25, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.92 per share. | Direct | 1,845 | Oct 24, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.49 per share. | Direct | 1,684 | Oct 19, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.27 per share. | Direct | 1,601 | Oct 17, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.22 per share. | Direct | 3,165 | Oct 13, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.30 per share. | Direct | 1,612 | Oct 5, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.20 per share. | Direct | 1,575 | Oct 2, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.21 per share. | Direct | 1,579 | Sep 28, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 3.88 per share. | Direct | 1,455 | Sep 26, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.23 per share. | Direct | 1,586 | Sep 20, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.40 per share. | Direct | 1,650 | Sep 18, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.58 per share. | Direct | 1,718 | Sep 14, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.81 per share. | Direct | 1,804 | Sep 11, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.76 per share. | Direct | 1,785 | Sep 7, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.90 per share. | Direct | 1,838 | Sep 5, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.48 per share. | Direct | 1,680 | Aug 31, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.44 per share. | Direct | 1,665 | Aug 28, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.54 per share. | Direct | 1,702 | Aug 24, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 4.07 per share. | Direct | 1,526 | Aug 21, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 3.81 per share. | Direct | 1,429 | Aug 18, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 3.70 per share. | Direct | 1,388 | Aug 14, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 3.55 per share. | Direct | 2,662 | Aug 11, 2017 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 0.52 per share. | Direct | 518 | Jul 14, 2015 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 0.53 per share. | Direct | 530 | Jul 13, 2015 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 0.47 - 0.51 per share. | Direct | 979 | Jul 7, 2015 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 0.44 - 0.45 per share. | Direct | 899 | Jul 1, 2015 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 0.47 per share. | Direct | 468 | Jun 23, 2015 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 0.41 per share. | Direct | 415 | Jun 22, 2015 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 0.44 per share. | Direct | 442 | Jun 16, 2015 |
| MISSLING CHRISTOPHER U Chief Executive Officer | Purchase at price 0.43 per share. | Direct | 428 | Jun 15, 2015 |
Related Tickers
ANVS Annovis Bio, Inc.
13.60
+6.75%
SAVA Cassava Sciences, Inc.
21.73
+4.77%
SAVAW Cassava Sciences, Inc.
0.3101
+40.89%
AXSM Axsome Therapeutics, Inc.
71.52
+0.49%
INMB INmune Bio, Inc.
10.84
+2.07%
ALT Altimmune, Inc.
7.20
+1.69%
MCRB Seres Therapeutics, Inc.
0.7427
+1.81%
SLS SELLAS Life Sciences Group, Inc.
1.5200
-1.30%
NWBO Northwest Biotherapeutics, Inc.
0.4770
+3.67%
TGTX TG Therapeutics, Inc.
13.91
-0.50%